Zenrelia is a new JAK inhibitor which Elanco says provides visible itch relief which lasts 24 hours, from the first dose.1
The company also points to a head-to-head study with over 330 dogs across 25 vet clinics, in which Zenrelia was shown to get nearly 50% more itchy dogs back to normal than Apoquel (oclacitinib).1
Elanco says its once-daily dosing may also improve treatment compliance over twice-daily alternatives.
The company also says that Zenrelia has a cost benefit too, presumably meaning it's cheaper than alternatives.
Zenrelia can be given long term with commonly used medications, including vaccines, antibiotics, parasiticides and NSAIDs.
Elanco UK & Ireland General Manager Matthew Frost said: “With this treatment, we’re looking at happier dogs and their owners, and a more rewarding experience for vets.”
www.zenrelia.co.uk
Reference
There are four events: two webinars, a face-to-face event with a workshop and a presentation at this year’s BVNA Congress.
The first webinar: ‘OA pain, awareness and management: how veterinary teams can collaborate to effectively manage OA’, takes place on Thursday 7th August (7-8pm).
The second webinar: ‘Librela clinical update; 4 years of clinical experience’ is on Tuesday 19th August (7-8pm).
The face-to-face event: ‘OA pain, awareness and management: how veterinary teams can collaborate to effectively manage OA’ and ‘Librela clinical update; 4 years of clinical experience’ plus practical application workshops, is on Saturday 6th September (10am-1pm) at BVNA HQ Harlow, Essex.
Finally, the BVNA Congress presentation: ‘The Joint Approach; the importance of the nursing team in OA diagnosis and management is on Sunday 12th October (9-10am) and it is free for everyone.
Jayne Clark, Zoetis National Veterinary Manager, Pain. “We are aiming for the talks to enhance delegates’ confidence in navigating aspects of pain management in dogs and cats so that they can support pet and owners with the latest knowledge, in a highly informed, confident and objective way.”
https://bvna.org.uk/events
David, Appleton Professor in Equine Surgery, University of Florida (pictured, left), says that despite considerable progress since the 1970's, largely through improved understanding of the diseases involved, diagnostic methods, surgical equipment and materials, and specialised training of surgeons, lingering problems remain and need to be addressed at all levels, not just by surgeons.
He said: “The current high cost of colic surgery can deny many horses a life-saving procedure.
"Pessimism is likely the product of past failures and overemphasis of treatments that are inappropriate or misdirected.
"Delays in referral might seem minor but have devastatingly harmful effects on outcome.
"Owners, primary care veterinarians, and surgeons need to establish an approach to colic based on teamwork, education, and rejection of myths that are widely promulgated.
"I will be looking at the key elements of progress and how they can be applied for future success.”
Professor Scott Weese (pictured right) is Director of the Centre for Public Health and Zoonoses at the University of Guelph.
He will present: "Misconceptions, Myths and Dogmas: moving past old barriers to optimise antimicrobial use in horses", which will challenge the audience to think about what they do with antibiotics and why, with the aim of introducing practical steps to optimise antimicrobial use, leading to improved patient outcomes, easier treatment and minimisation of negative consequences.
Scott said: “We do a lot of things simply because we’ve done them, not because they work or make sense, and we need to look at what we’re doing and the available evidence.
"I will discuss some well-established dogmas that don’t actually make sense, cover some common questions and misconceptions about antibiotic use, and try to help us advance how we use these life-saving drugs that, to some degree, are a non-renewable resource.”
Scott will also be presenting a talk about sampling on the Friday in the antimicrobial stewardship session, with the aim of getting everyone thinking about how we make antibiotic decisions: “There’s a lot of emphasis on submitting cultures, but if we submit bad samples or can’t interpret them, it’s at best a waste of money and at worst can harm patients.”
Book before 6th August to take advantage of early bird prices for BEVA members of £599 for a three-day pass for vets (normal price £699) and £225 for vet nurses (normal price £273) (with concessionary rates available for those in their first three years of graduation or earning less than £25,000).
Day tickets and practice passes are also available.
Early bird rates and practice passes are available until 6 August 2025.
http://www.bevacongress.org
The project was launched in 2016 to identify and find solutions to some of the specific issues facing the veterinary nursing profession.
However, the organisations say that whilst they both want to make sure veterinary nursing remains a vibrant, rewarding and sustainable profession, they now recognise the benefits of the regulator and the representative body working more independently.
Lyndsay Hughes, BVNA President, said: “The joint decision to end the project marks an end of an era, but also the beginning of an exciting new chapter.
"We will continue to work with each other on activities and projects that support the veterinary nursing profession on an ongoing basis.”
To that end, the RCVS and BVNA have identified the need to continue to drive the effective use of veterinary nurses within the wider veterinary team, in order to promote job satisfaction, progression opportunities and excellent standards of patient care.
The BVNA published resources earlier this year designed to help maximise the RVN role within the current legislation, and there's a ‘RVN utilisation champions’ campaign launching later this year, and streams on the subject at BVNA Congress in October.
The association is also preparing a ‘Nurse Utilisation Toolkit’ which is due to launch in late 2025/early 2026 - to provide members with access to resources on how to implement and support effective use of nurses in the workplace.
The RCVS has recently launched the second phase of the VN Vision initiative which aims to inspire a cultural shift in how veterinary nurses can be more effectively integrated within multidisciplinary veterinary teams, and explore why doing so is essential for the future of veterinary healthcare.
A series of workshops ‘A vision or a necessity: strengthening the role of veterinary nurses in team-based veterinary healthcare’ is being held across the UK for all members of the veterinary team this year, with an additional session being held at BVNA Congress.
https://vnfutures.org.uk
This allows patients to try the drug at lower cost, before progressing to the 30ml bottle for ongoing treatment.
Samantha Taylor, RCVS Recognised Specialist in Feline Medicine said: “It’s great we now have the option to prescribe the smaller 12ML bottle for starting cats on Senvelgo, as it means we don’t have to worry about wasting a 30ml bottle if it becomes evident that the cat requires insulin in the first couple of weeks.”
https://senvelgo.co.uk
The new oncology department has a dedicated chemotherapy room, access to a variety of chemotherapy drugs and a fully equipped operating theatre – offering soft tissue and orthopaedic surgery services for surgical oncology cases.
The department also has access to high frequency ocular ultrasound, magnetic resonance (MRI), and computed tomography (CT) scan equipment.
The service will be led by residency-trained clinician in Small Animal Oncology, Nina Vigevani DVM MRCVS.
She graduated in 2019 from the University of Milan, completed a rotating internship and worked in general practice in Milan, before moving to the UK to start on an oncology internship at a referral practice in the South of England.
Prior to moving to Chestergates, she completed her Residency in Small Animal Oncology at the University of Liverpool.
https://chestergates.org.uk/referral-services.
The authors say the research marks a significant step forward in understanding how veterinary surgeons and owners can more effectively manage and prevent outbreaks of the disease.
For the study, researchers from the RVC, the University of Cambridge, the Swedish University of Agricultural Sciences and Redwings Horse Sanctuary, analysed more than 500 S. equi samples from across the UK between 2016 and 2022.
In particular, they wanted to better understand the relative contribution of short-term (immediately post infection) versus long-term carriers (carriers that were infected months or years prior).
The samples were collected from clinical cases sent to diagnostic laboratories by veterinary surgeons seeking confirmation of infection.
Surplus samples were submitted to the Surveillance of Equine Strangles network and then cultured in the RVC’s research laboratory and their DNA extracted and sequenced to reveal each bacterium’s complete genetic code.
Adopting an approach that combined whole genome sequencing and epidemiological data, the researchers were able to trace how strains are related and have evolved.
With the use of computer programmes, they also tracked how genetically related strains spread between horses and across regions, over time.
By adopting this approach, the team was also able to pinpoint likely transmission events and chains of infection.
The main findings were:
The research highlights the need for early diagnosis, isolation and laboratory-confirmed clearance, particularly through guttural pouch testing, before assuming a horse is infection-free.
It also advocates for tighter biosecurity and movement protocols, especially when transporting horses across regions.
Dr Abigail McGlennon, former PhD student in the Department of Pathobiology and Population Sciences at the RVC, and lead author of the paper, said: “Strangles is a challenging and distressing disease for horses, owners, yards and vets, and this work has highlighted just how easily it can be spread across the UK in a short period of time.
“This study shows how important enhanced surveillance utilising epidemiological and genomic data is to investigate and understand strangles transmission across the UK.
"Our data highlights the importance of greater awareness and adoption of post-outbreak screening protocols to confirm freedom from infection, rather than owners assuming recovery based on the resolution of clinical signs.”
The new Tosoh AIA 900 analysers have been trialled for the last 18 months at Liphook Equine Hospital, which was the first practice to introduce ACTH testing for horses 25 years ago and gets hundreds of blood samples every week from veterinary practices all over the UK and Europe.
Professor Andy Durham, who heads up the laboratory at Liphook, said the test period has shown that the new machine produces more accurate results primarily because it’s less sensitive to ACTH degrading in blood samples between collection and receipt by the laboratory.
Andy said: “There are several analytic methods available for use in horses, and we wanted to see if this alternative machine had diagnostic benefits over the ones we’d used previously.
"The ACTH molecule we test for immediately begins to break down after a blood sample is taken, even if you handle it carefully and place it in chilled packaging, but this new analyser is able to detect much more of the degraded ACTH molecule, and therefore it gives a more accurate result.
“As a comparison, ACTH values measured using the previous method suffered about three to four times more degradation over 24 hours.
"What this means for horse owners is that it will reduce the risk of false negative results in ACTH tests, so more horses suffering from Cushing’s disease will receive the treatment they need.”
In testing, the new analysers also demonstrated greater accuracy when measuring insulin levels in blood samples.
https://liphookequinehospital.co.ukhttps://www.rainbowequinehospital.co.uk https://www.rossdales.com
'Evidence-based veterinary medicine at 20 – a commentary on historical, philosophical, practical, and ethical aspects' by David Mills MRCVS, Michael J. Reiss and Madeleine Campbell FRCVS, looks at the history of both evidence-based medicine and EBVM, the moral and ethical arguments for EBVM and the practical barriers.
It concludes that EBVM would be improved by:
Author David Mills MRCVS said: “EBVM has extensively infiltrated the veterinary discourse in the last 20 years and whilst it seems a sensible way of doing medicine, this doesn't always translate into practical improvements.
"Of course we need to base decisions on evidence, and the more reliable that evidence the better the decisions are likely to be.
"But is EBVM the best way?
"Does it serve the individual when the evidence doesn't relate to them or the specifics of their disease?
"Does EBVM help or hinder us in realising welfare improvements for the individual animal?
"In this review of the EBVM movement we examine aspects of the methodology and its practical application and in several areas find it wanting.
"Some of these are practical issues - for example underpowered studies, poor evidence - whilst others are fundamental to the philosophy and practice of EBVM itself such as what is evidence, how it translates to individuals and how we cannot predict the future.
"Evidence-based medicine was forged in the fires of not just accepting eminent pronouncements - in this paper we apply this principle to EBVM itself."
https://veterinaryevidence.org/index.php/ve/article/view/710
The RCVS Regional Question Time sessions give members of the profession a chance to learn about College projects and initiatives directly from the RCVS Officer team, Council members, and senior staff.
There is also an opportunity for open dialogue, where any queries can be raised with the RCVS, in a friendly, informal environment.
Both events will begin with supper and drinks at 6.30pm.
The College says discussion topics will be audience-led but are likely to cover current important topics including workforce issues, the benefits of a new Veterinary Surgeons Act, extra-mural studies (EMS), governance reform, the impact of VetGDP, the Practice Standards Scheme (PSS), and the Competition and Markets Authority investigation.
RCVS President, Tim Parkin, said: “It’s an exciting time for me as I embark on my presidential year, and I’m truly looking forward to engaging with members of our wonderful professions about the issues that matter most to them.
“As I mentioned previously at Royal College Day, we’re currently facing some significant and ongoing challenges – from the CMA investigation and workforce issues, to the critical need for a new Veterinary Surgeons Act.
“Now more than ever, it's essential that we recognise the need for change and commit to engaging with one another in a clear, compassionate, and respectful way.
"Please do come and speak with us at either event – meaningful change cannot happen in silos; we must work together to make progress and your input is key.”
https://www.eventbrite.com/cc/rcvs-question-time-4465993
The Ageing Canine Toolkit, which was developed from research carried out by the University of Liverpool, aims to help both vets and owners provide the best care for senior and geriatric dogs.
It includes information about common health problems that affect ageing dogs and a colour-coded checklist to help owners know when to seek advice from a veterinary practice and how to guide discussions during consultations.
As part of the partnership, NationWide Laboratories will be distributing the toolkit to its clients, helping raise awareness and make sure that the owners of older dogs know how to look for signs of disease which could enable treatment to be started earlier.
Alison Selby, Fundraising Manager for BSAVA PetSavers said: “We are thrilled to be embarking on this partnership with NationWide Laboratories.
"By supporting the print and distribution costs of this invaluable resource, they will help us reach more pet owners across the UK.
"Working together in partnership, we hope to equip owners with the knowledge and confidence to support their dogs through the ageing process, ultimately improving their quality of life.”
https://bsava.com/petsavers/our-impact/citizen-science-project
The new RVN Council members are: Emily Bacon RVN, Macauly Gatenby RVN, Dan Lidgbird RVN and Krishna Mistry RVN, with Alice Langstone taking the student seat.
The incoming BVNA officer team for the 2025/6 term is (pictured left to right): Sarah Holliday RVN – President, Lyndsay Hughes RVN – Senior Vice President, Steph Worsley RVN – Junior Vice President, Nikki McLeod RVN – Honorary Secretary, Hamish Morrin RVN – Honorary Treasurer.
The company's teleradiology and education services are not affected, and will continue as normal.
VET.CT's CEO, Victoria Johnson said: “We are deeply sorry to have to close our teleconsulting specialist case advice service.
"Despite many loyal clients loving it and using the service to the full, wider adoption of teleconsulting has been variable globally since its launch in 2018.
"We have continued to consult, invest in, iterate and adapt the service over the past 7 years to unlock the demand.
"However, despite our efforts, we now have to take the painful and difficult decision to close our client-facing service.
"There are a multiplicity of factors that contribute to the issue and sadly, the ongoing economic pressures mean that the teleconsulting service is no longer sustainable.
"We want to reassure our clients that our quality-focused radiology reporting and education services are unaffected by these changes and continue to grow.
https://resources.vet-ct.com/statement-about-teleconsulting-service
The Awards are open to all organisations and practice teams across the UK who are using recognised QI techniques to improve outcomes.
The Award categories are as follows:
Ashley Doorly, Head of Quality Improvement at RCVS Knowledge, said: “Now in its seventh year, the RCVS Knowledge Awards continue to highlight the incredible work being done across the veterinary professions to improve patient safety and outcomes, boost team morale, embed evidence-based veterinary medicine, and support more fulfilling careers.
"Over the years, we’ve seen how strong team culture lays the foundation for successful Quality Improvement projects.
“This year, we’re especially excited to receive applications that explore emerging priorities such as sustainability, One Health, and contextualised care.”
https://knowledge.rcvs.org.uk/awards/rcvs-knowledge-awards
The service is designed to make vital support more accessible to those clients who may face challenges visiting the practice, whether that's down to limited mobility, transport difficulties, or simply a pet’s anxiety with travel.
Led by experienced RVNs, the service includes:
Judith Lee, Small Animal Director at Oakhill Veterinary Centre, said: “Our Community Vet Nurse service is all about making it easier for our clients to access the help they need."
https://www.oakhill-vets.com/pets/community-vet-nurse/
The library currently has 28 on-demand recordings, covering a range of sessions on three main themes: people, planet and animals.
They include: ‘Managing emotions in stressful situation’ and ‘Shaping practice culture as a team’, and BVA Congress recordings, such as "Is neutering dogs doing more harm than good?".
BVA President Elizabeth Mullineaux said: “All veterinary professionals will understand the crucial role that CPD plays in maintaining and enhancing our knowledge and skills.
"Whether you're catching up on missed sessions or looking to revisit key topics, the new BVA CPD library can help members stay up to date throughout your career.”
https://mybva.bva.co.uk/cpd-library.html
This year sees BVNA continue a theme of ‘Progression’, to mirror the association’s 60th anniversary year and recognise the progress made in the VN profession during this time.
There will be no less than twenty lecture streams covering:
There will also be hands-on workshops, small group discussions, and drop-in practical learning events throughout.
https://bvna.org.uk/congress
Mr Seymour-Hamilton was originally struck off in 1994 after his Kent practice was found to be unhygienic and unsterile with poor record keeping.
However, he has always maintained that the reason his premises were unhygienic and unsterile was because they were closed.
As in previous applications, he said his reason for applying for restoration was to help him gain recognition for his alleged herbal and natural remedy discoveries and that he had no intention of going back into general practice.
As with previous applications, the Committee said that Mr Seymour-Hamilton has shown no real insight into the conduct underlying the original findings and nor has he shown insight into matters identified by previous restoration hearings.
The Committee also considered that Mr Seymour-Hamilton has been off the Register for some 31 years and would therefore need prolonged, intensive, formal retraining to ensure that he was now fit to practise, without which he might pose a risk to animal welfare.
Mr Seymour-Hamilton's case was not helped by the fact that he indicated that he had practised veterinary surgery while off the Register – including conducting two spay procedures in Calais, France, and treating two of his own dogs for cancer.
He also referred to having cultured faecal bacteria in a witness’ kitchen.
The Committee felt it was concerning that Mr Seymour-Hamilton thought these things were compatible with being on the Register and upholding the professional standards expected of a veterinary surgeon.
Paul Morris, chairing the Committee and speaking on its behalf, said: “Mr Seymour-Hamilton still lacks an understanding as to why he has not been restored in the past.
"Apart from additional CPD, he has not set about effectively addressing any of his shortcomings.
"He relies passionately on his research, yet he does not support that research with any peer-reviewed publications, indeed all his attempts to gain recognition have been rebuffed.”
He added: “The Committee is firmly of the view that after such a prolonged period of failing to be reinstated as a veterinary surgeon, Mr Seymour-Hamilton has to face the reality that his continued applications, taking up time, resources and expense (which is ultimately borne by all those veterinary surgeons who are on the Register), are vexatious and ultimately unlikely to succeed.
“Whilst the College cannot prevent him from continuing to apply to be restored to the Register, Mr Seymour-Hamilton should by now realise that this is not a good use of the College’s finite resources.
"He is now 86 years old and has not practised for over thirty years and in fact has now been off the Register for longer than he was on it.
"This is now the twelfth time he has been found to be not fit to be restored to the Register.
"The Committee hopes Mr Seymour-Hamilton will now take time seriously to reflect and take into account the impact to all concerned of his continued applications, before deciding to submit any more.”
https://www.rcvs.org.uk/concerns/disciplinary-hearings
The new resource is designed to help dog owners understand the risks of cancer, recognise the importance of early detection, and learn how HT Vista’s cancer detection device supports veterinary teams in screening suspicious masses.
It includes guidance on the early warning signs of cancer in dogs and explains how acting quickly can improve outcomes.
Dr Liron Levy-Hirsch, Veterinary Surgeon and Managing Director at HT Vista said: “We believe informed pet owners are key to driving earlier diagnosis.
"This new page is all about bridging the gap between innovative veterinary technology and the people it’s designed to support.
"By empowering pet owners with clear and trustworthy information, we hope to strengthen understanding of the diagnostic process, support clinical decision-making, and ultimately help more dogs receive timely treatment.”
www.ht-vet.com/petowners
In the webinar, which is sponsored by Horiba, Ian will present an update on new exotic parasite infections and distribution across the UK and Europe, and what this means for pets, livestock and the people that care for them.
“New Exotic Parasites – Worming Their Way In?” is suitable for vets, nurses, students and veterinary care assistants.
https://horiba.link/4h2.
Jonathan Hill, UK country manager at Dômes Pharma said: "Dômes Pharma is really excited to be extending our pet anxiety range to help vets manage cases in this complex area.
https://domespharma.co.uk/products/fluoxevet/
The merger brings together Improve International’s global reach and postgraduate qualification programmes with Central CPD’s practitioner-led Continuing Professional Development training and digital learning infrastructure.
Improve says the merger will better position the two companies to meet the growing and evolving needs of the profession.
However, the veterinary training marketplace has been hit recently by news that IVC Evidensia has opened two in-house training centres, one in Scotland and one in the Midlands, perhaps precipitating some consolidation, especially since IVC has announced plans to offer CPD to the wider profession later this year.
UK Pet Food says that with pet owners increasingly turning to their vets for nutrition guidance, this course is designed to equip veterinary teams with the knowledge and confidence to offer clear, evidence-based advice.
The course offers 20 hours of CPD comprised of on-demand modules and live Q&A sessions covering pet food formats, clinical nutrition, pet obesity, regulatory frameworks, sustainability, and client communication.
There'll be contributions from independent speakers and chairs from leading academics, veterinary nutritionists, and industry experts
Sarah Hormozi, Head of Science & Education at UK Pet Food, said: “This course is about helping veterinary professionals critically evaluate the science behind pet nutrition.
“We’ve worked with board-certified veterinary nutritionists, academics, industry experts, and veterinary associations to develop a resource that supports everyday clinical conversation - giving the veterinary community practical tools and confidence to talk about pet food and nutrition with clarity and credibility.”
There are early bird tickets for £90 if you book by 15th August 2025.
https://thewebinarvet.com/events/uk-pet-food-2025
https://www.ukpetfood.org
Photo: www.depositphotos.com
The BSAVA says there unique opportunities and risks to the use of antibiotics in rabbits.
For example, antibiotic combination therapy, which is discouraged in dogs and cats, can be safe and effective in this species.
Also, careful selection of appropriate antibiotics, in terms of active substance, dose and route of administration, is crucial when treating rabbits due to the risk of enterotoxaemia.The new guide gives advice on diagnosing bacterial infections, likely causal organisms and appropriate antibiotic and non-antibiotic management.
The guide covers dacryocystitis, ear disease, facial abscesses, enteritis, urinary tract disease, and upper and lower respiratory tract disease.John Chitty, one of the authors, said: “Choosing an antibiotic for rabbits is not simple.
"Their diseases do not necessarily mirror those of dogs and cats, and they do have gut sensitivities to certain antimicrobials.
"However, like dogs and cats, there are situations where antibiotics are not needed where we once thought they were.
"This is especially important in reducing antibiotic usage in rabbits and, of course, in reducing use of critically important antibiotics in them as well.
"We hope this guide will help practitioners to see when antibiosis is needed, what choices are available and how to sample and select the most appropriate drug if needed.”The new guide is free to all and can be accessed at bsavalibrary.com/protectme.
Krka says Arocenia provides fast, broad-spectrum anti-emetic efficacy with a 24-hour duration of action following a single daily dose.
It can be administered intravenously or subcutaneously and is supplied in 20 ml multi-dose vials, allowing up to 40 punctures per vial and a 60-day open vial shelf life.
Renzo Di Florio, Krka’s Technical Veterinary Adviser, commented “Vomiting is one of the most common presenting signs in small animal practice, and maropitant is a medication you’ll find on just about every vet’s dispensary shelf. With Arocenia, we’re adding a cost-effective formulation to the available options.”
https://www.krka.co.uk//products/our-products/animal-health/arocenia-10mgml-solution-for-injection